Sanofi announced today that its Q3 2024 Aide mémoire is available on the "Investors" page of the company's website: ...

EADV: New data reinforce Sanofi’s innovative approach and leadership across immune-mediated skin diseases 24 abstracts for Dupixent, including 4 oral presentations, highlight impact of ...

Nous transformons les miracles de la science en réalité pour fournir chaque année plus de 5 milliards de solutions de soins de santé à des personnes à travers le monde. La production et ...

Parfois, l’innovation technologique peut provenir d’espace inattendus. Dans le développement de médicaments, cela signifie souvent l’intersection de technologies apparemment sans rapport ou de ...

Sometimes transformative technology comes from unexpected places. In drug development, that often means the intersection of seemingly unrelated technologies or esoteric areas of science. French ...

As Premium Partner of the Paris 2024 Olympic and Paralympic Games and Official Partner of the Paris 2024 Olympic and Paralympic Torches Relays, we celebrate human achievement across various frontiers.

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly ...